S-0.1, r. 12.1 - Regulation respecting the drugs that may be prescribed or administered by a midwife

Updated to 16 December 2020

This document has official status.

not in force

chapter S-0.1, r. 12.1

Regulation respecting the drugs that may be prescribed or administered by a midwife

Midwives Act

(chapter S-0.1, s. 9, 1st par.).

1. A midwife may, in the practice of the profession, prescribe or administer the drugs listed in the Schedule.

O.C. 1376-2020, s. 1.

2. Despite section 1, a midwife who has obtained a permit to practise before 1 April 2022 must, to prescribe or administer the drugs listed in the Schedule, have completed the training of not more than 12 hours recognized by the Ordre des sages-femmes du Québec on the prescription and administration of drugs in accordance with this Regulation.

O.C. 1376-2020, s. 2.

3. This Regulation replaces the Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery (chapter S-0.1, r. 12).

O.C. 1376-2020, s. 3.

4. (Omitted).

O.C. 1376-2020, s. 4.

SCHEDULE

(ss. 1 and 2)

DRUGS THAT MAY BE PRESCRIBED OR ADMINISTERED BY A MIDWIFE

NOTE: The following classification refers to the classification prepared by the American Hospital Formulary Service.

1. Every drug belonging to the following classification, subject to the restrictions indicated:

Restrictions:

AM	Only for the purposes of breastfeeding.
CH	Only in a hospital centre operated by an institution within the meaning of the Act respecting health services and social services (chapter S-4.2) or the Act respecting health services and social services for Cree Native persons (chapter S-5).
PI	Only as part of first-line treatment or if the prescription or administration of the drug as part of second or thirdline treatment constitutes a prophylactic measure in accordance with the clinical practices in force.
S	May only be prescribed.
T	Only while waiting for medical care where transfer of the clinical responsibility of the mother or child to a physician is necessary.

THERAPEUTIC CLASSES	THERAPEUTIC SUBCLASSES	SUB-SUBCLASSES THERAPEUTIC	RESTRICTIONS
Antihistamines	First generation antihistamines	Ethanolamine derivatives
Anti-infective agents	Antibacterial agents	Aminoglycosides	PI and T
		Cephalosporins	PI
		Macrolides	PI
		Penicillins	PI
		Sulfonamides	PI
		Other antibacterial agents	PI
	Antifungals	Azoles
		Polyenes
	Antivirals	Nucleoside and nucleotide analogs
	Antiprotozoals	Miscellaneous antiprotozoals
	Urinary anti-infective agents
Autonomic nervous system (A.N.S.) drugs	Sympathomimetics	Alpha and beta adrenergic agonists	T
Blood medication	Antianemics
Cardiovascular drugs	Vasilodilators	Nitrates and nitrites	T
	Beta-adrenergic blockers		T
	Calcium channel blocker	Dihydropyridines	T except for a drug for treating nipple vasospasm
Central nervous system (C.N.S) drugs	Analgesics and antipyretics	Non-steroidal anti-inflammatories
		Opiate agonists	CH
		Opiate partial agonists	CH
		Miscellaneous analgesics and antipyretics
	Narcotic antidotes		T and CH
	Anticonvulsants	Miscellaneous anticonvulsants	T
	Anxiolytics, sedatives and hypnotics	Benzodiazepines
	Miscellaneous (C.N.S) drugs		T
Diagnostic agents	Diabetes mellitus
	Urine and stool analyses
Electrolytes-diuretics	Replacement agents
	Caloric agents
Eye, ear nose and throat (E.E.N.T.) preparations	E.E.N.T. anti-infective agents	Antibiotics
Gastrointestinal drugs	Antiemetics	Antihistamines
		Other antiemetics
	Antiulcer agents and antacids	Histamine H2-receptor antagonists
		Prostaglandins
		Gastro-duodenal cytoprotective agent	AM
		Proton pump inhibitor
	Procinetics		AM
Hormones and substitutes	Corticosteroids		T
	Oral contraceptives		S
	Progestogens
Local anasthetics
Ocytocics
Immunizing agents	Passive immunotherapy agents
	Active immunotherapy agents
Skin and mucous membranes	Anti-infective agents	Antibacterial agents
		Antifungals
		Other local anti-infective agents
	Anti-inflammatories
	Antipruritics and local anesthetics
Vitamins

2. Any other drug that is not listed in Schedule I of the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12).

3. Any combination of drugs in this Schedule, subject to applicable restrictions.

O.C. 1376-2020, Sch.

REFERENCES

O.C. 1376-2020, 2021 G.O. 2, 86